An underground market for unapproved weight-loss medications is being driven by TikTok fitness influencers and sellers on communication apps, according to new investigations.
Experimental Treatment Gaining Traction Online
The experimental drug, which remains in clinical trials, is being advertised by social media influencers for its supposed weight-reducing effects. Viewers are urged to contact these profiles directly for supplier links, while also obtaining discount codes.
Active Commerce on Messaging Platforms
Additionally, a robust market exists on messaging services, where groups with thousands of members share comparison photos, injection guides and assertions of rapid British shipping. Sellers market the substance there before redirecting buyers to WhatsApp for purchases.
Understanding Retatrutide
This medication is an investigational injection developed by US drugmaker Eli Lilly. The drug affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could assist individuals lose up to 25% of their total weight. Nicknamed the “triple G”, the substance is being promoted digitally as the successor to Ozempic.
Medical Professionals Voice Concerns
However, doctors and chemists have cautions that the distribution of what is still an unapproved medication in the UK is a cause for concern and could result in individuals injecting substances of unknown origin.
Some experts stated the demand for retatrutide could be connected to the rising cost of licensed weight loss treatments such as Mounjaro.
Regulatory Position and Enforcement
Marketing retatrutide on TikTok or Telegram is prohibited in the UK, as it is an unapproved drug that cannot be marketed or supplied for personal consumption under the British medical regulations.
Several content creators try to circumvent the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and supply can still violate pharmaceutical, advertising, and consumer regulations, potentially leading to fines, prosecution or imprisonment.
Platform Reaction and Content Removal
Based on the social media company, the service has removed violative content and prohibited related hashtags and search suggestions. The company said it was dedicated to keeping the platform safe and allocating resources in strengthening enforcement strategies.
Online Trading Operations
Investigations also found groups with up to 9,000 participants selling the experimental drug using the platform's integrated search feature, which operates like a public directory. Typing “retatrutide” instantly displays channels with numerous of users, populated with images of slimming results, positive testimonials and step-by-step instructions for preparing or administering at residence.
After minutes of joining one community, a vendor posted WhatsApp details, where most transactions occur. The seller provided an instruction manual and promised delivery within 48 hours. When questioned whether the substance was genuine, one seller said: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. None inquired about body mass, medical conditions or previous experience.
Item Information and Pricing
Within these communities, posts show dark colored parcels with Royal Mail labels, stating to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”
Customers can select between powder vials, prepared at residence with purified liquid, or ready-to-use injectors usually sold at £160 for 20 milligrams. When asked how long a injector should be used, sellers give contradictory responses ranging from a several days to “depends on your body”.
Platform Moderation and Security Actions
A spokesperson for the messaging service said it regularly monitored harmful material on its platform including material that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“People are injecting substances they can’t verify. Even if the science behind this drug is valid, these online products may not contain what they advertise,” stated Jason Murphy, the head of pharmaceutical services at Chemist4U.
Dr Crystal Wyllie of an online medical service linked the increase in demand to recent price rises for approved weight-loss drugs such as Mounjaro. “With prices rising, patients are turning to online platforms. But fake injections are highly risky. You can’t be certain what’s contained or whether the environment they were produced in was clean,” she explained.
Her team has previously seen patients injured by self-injection from unverified suppliers. “We understand the frustration, but buying from Telegram or WhatsApp is gambling with your health,” said the doctor. “These substances could be impure or incorrectly dosed.”
Manufacturer Position
A representative from Eli Lilly stated the substance was in phase 3 clinical trials and had not been reviewed or approved by any regulatory agency globally. “Consequently at this point no one can sell [it] for human use,” they explained, adding that any product “misleadingly claiming itself as a Lilly investigational product not yet authorized … may subject patients to possibly significant health risks”.
